Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
SPERSALLERG (oc u lar anti-al ler gic/de con ges -<br />
tant/an ti sep tic)<br />
VISCOTEARS (ar ti fi cial tears/oc u lar lu bri cant)<br />
SPERSADEX (ophthalmological corticosteroid)<br />
OCULAC (ar ti fi cial tears/oc u lar lu bri cant)<br />
Ther a peu tic Range:<br />
ophthalmologicals 100%<br />
Lead ing Dose Forms:<br />
liq uids 73%<br />
gels/sols 16%<br />
vi als 9%<br />
oint ments 2%<br />
HEXAL<br />
Full Name: Hexal A/S<br />
Street Ad dress: Jernbaneveien 4, N-1400 Ski<br />
Tel: +47 64 91 30 00<br />
Fax: +47 64 85 09 30<br />
Email: post@hexal.no<br />
Home Page: www.hexal.no<br />
Con tacts (Pharm): Chair man: Bo Skauen;<br />
Com mer cial Op er a tions: Rolf Sveen; Gen eral<br />
Con tact: Tor Solheim<br />
Phar ma ceu ti cal Sales: US$ 4-5 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 70-75%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 75-80%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
CLOZAPIN HEXAL (antipsychotic)<br />
CARVEDILOL HEXAL (beta-blocker agent plain)<br />
CIPROFLOXACIN HEX (fluoroquinolone)<br />
LORATADIN GEA (an ti his ta mine sys temic)<br />
CETIRIZIN HEXAL (an ti his ta mine sys temic)<br />
Ther a peu tic Range:<br />
psycholeptics 24%<br />
beta-block ing agents 20%<br />
an ti his ta mines sys temic 15%<br />
antibacterials sys temic 12%<br />
ant ac ids/antiflatulents/antiulcerants 5%<br />
Lead ing Dose Forms:<br />
tab lets 71%<br />
coated tab lets 24%<br />
cap sules 5%<br />
liq uids -<br />
creams -<br />
NOVARTIS<br />
Full Name: Novartis Norge AS<br />
Postal Ad dress: Postboks 237, N-0510 Oslo<br />
Street Ad dress: Brynsalleen 4, N-0667 Oslo<br />
Tel: +47 23 05 20 00<br />
Fax: +47 23 05 20 01<br />
Email: medisinsk.informasjon@novartis.com<br />
Home Page: www.novartis.no<br />
De scrip tion: Re searcher, pro moter,<br />
sales/detailer. Prod uct ranges in clude: phar ma -<br />
ceu ti cal prod ucts (branded, pre scrip tion,<br />
non-pre scrip tion), hos pi tal pharmaceuticals, vet -<br />
er i nary pharmaceuticals, oph thal mic prod ucts.<br />
Es tab lished 1997. 111 phar ma ceu ti cal em ploy ees<br />
in 2008. Di vi sions in clude: Sandoz (Generics);<br />
Pharma; OTC; Animal Health.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 21-50 (2008)<br />
Con tacts (Pharm): Chair man: Kees Roks;<br />
Com mer cial Op er a tions: Kees Roks; Mar ket Re -<br />
search: Petter Foss; Re search & De vel op ment:<br />
Tove Karlsrud<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 100-110 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 50-55%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 60-65%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
80-85%<br />
Prin ci pal Prod ucts:<br />
OTRIVIN (na sal prep a ra tion top i cal)<br />
SANDIMMUN NEORAL (immunosuppressive<br />
agent)<br />
GLIVEC (antineoplastic other)<br />
NICOTINELL (antismoking prod uct)<br />
SANDOSTATIN (hor mone hy po tha lamic)<br />
Ther a peu tic Range:<br />
na sal prep a ra tions 16%<br />
immunosuppressive agents 13%<br />
renin-an gio ten sin sys tem agents 12%<br />
CNS drugs other 11%<br />
antineoplastics 10%<br />
Lead ing Dose Forms:<br />
coated tab lets 20%<br />
tab lets 18%<br />
liq uids 18%<br />
cap sules 17%<br />
am poules 8%<br />
SANDOZ<br />
Full Name: Sandoz Pharma AS<br />
Street Ad dress: Jernbaneveien 4, N-1400 Ski<br />
Tel: +47 64 91 30 00<br />
Fax: +47 64 85 09 30<br />
Home Page: www.sandoz.no<br />
Phar ma ceu ti cal Sales: US$ 8-9 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 85-90%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 192
Change language